Competitive intelligence on 
 small-molecule drugs and 
 the 90,000 global patents 
 covering them 

Start your free trial now

DrugPatentWatch Ultimate Plan Preview

Details for Generic Name: oxybutynin chloride

« Back to Dashboard

Summary for Generic Name: oxybutynin chloride

Tradenames:4
Patents:7
Applicants:16
NDAs:20
Drug Master File Entries: see list16
Suppliers: see list5
Therapeutic Class:Genitourinary Agents

Pharmacology for Ingredient: oxybutynin chloride

Clinical Trials for: oxybutynin chloride

Evaluate the Efficacy of Oxybutynin Chloride in Patients With Primary Hyperhidrosis
Status: Not yet recruiting Condition: Hyperhidrosis

An Efficacy and Safety Study of Oxybutynin Chloride Oral Osmotic Therapeutic System (OROS) in Korean Overactive Bladder Participants
Status: Completed Condition: Urinary Bladder, Overactive

OnabotulinumtoxinA (onaBoNT-A) Versus Oral Oxybutynin ER
Status: Recruiting Condition: Overactive Bladder

Cognitive Effects of Oral Oxybutynin and Oxybutynin Chloride Topical Gel in Older Volunteers
Status: Completed Condition: Healthy Volunteers

The Effect of Extended-Release Oxybutynin Chloride on Vasomotor Symptoms in Healthy Post-Menopausal Women
Status: Completed Condition: Menopause; Hot Flashes

Use of Oxybutynin for Treating Hyperhidrosis: A Placebo-control Study
Status: Completed Condition: Hyperhidrosis

Treatment of Hyperhidrosis With Oxybutynin
Status: Completed Condition: Hyperhidrosis

Food Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg
Status: Completed Condition: Healthy

Fasting Study of Oxybutynin Chloride ER Tablets 10 mg and Ditropan XL® Tablets 10 mg
Status: Completed Condition: Healthy

Fed Study of Oxybutynin Chloride Extended-Release Tablets 10 mg and Ditropan XL® Tablets 10 mg
Status: Completed Condition: Healthy

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Watson Labs
OXYBUTYNIN CHLORIDE
oxybutynin chloride
TABLET;ORAL072485Apr 19, 1989DISCNNo<disabled><disabled>
Silarx
OXYBUTYNIN CHLORIDE
oxybutynin chloride
SYRUP;ORAL074520Mar 29, 1996RXNo<disabled><disabled>
Watson Labs
GELNIQUE
oxybutynin chloride
GEL;TRANSDERMAL022204Jan 27, 2009RXYes8,241,662<disabled><disabled>
Janssen Pharms
DITROPAN XL
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL020897Jun 22, 1999RXYes5,840,754*PED<disabled>Y<disabled>
Janssen Pharms
DITROPAN XL
oxybutynin chloride
TABLET, EXTENDED RELEASE;ORAL020897Jun 22, 1999RXYes5,674,895*PED<disabled>Y<disabled>
This preview shows a limited data set
Subscribe for full access, or try a free trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

DrugPatentWatch Archives

You are viewing the current data set
Select a link below to view the archives:

 2000   2001   2002   2003   2004   2005   2006   2007   2008   2009   2010   2011   2012   2013   2014  

For more information try a free trial or see the plan comparison

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2015 thinkBiotech LLC
ISSN: 2162-2639

Preferred citation:

Friedman, Y. Location of pharmaceutical innovation: 2000–2009 Nature Reviews Drug Discovery 9, 835–836 (2010).

Connect with Social Media:

Follow DrugPatentWatch on Twitter
Connect with DrugPatentWatch on Linkedin
Drug Patents on LinkedIn
`abc